with an increased risk of bleeding, 7 early detection may be relevant in order to guide treatment changes.
Magnetic Resonance Imaging (MRI) is the most sensitive imaging modality to demonstrate early intra-articular joint changes. 8 As MRI is relatively expensive and time consuming, routine assessment of multiple joints of haemophilia patients is not feasible. As ultrasound showed to be highly accurate in assessing synovial hypertrophy, it may provide an alternative for MRI. [9] [10] [11] Various clinicians perform ultrasound examinations themselves for specific indications, known as point-of-care ultrasound (POC-US). 12 The "Haemophilia Early
Arthropathy Detection with Ultrasound" (HEAD-US) protocol has been developed to allow joint assessment in haemophilia by nonradiologists. 13 Although the HEAD-US protocol is increasingly used in addition to physical examination, the diagnostic accuracy of this POC-US protocol has not been evaluated yet. The primary objective of this study was to assess the diagnostic accuracy of POC-US for synovial hypertrophy in haemophilia patients by comparison with MRI. Secondary objectives were to assess the diagnostic accuracy of POC-US for the presence or absence of cartilage abnormalities and bone surface irregularities.
| MATERIAL S AND ME THODS
This diagnostic accuracy study was performed at the Van Creveldkliniek, University Medical Centre Utrecht, the Netherlands, and reported according to the "Standards for the Reporting of Diagnostic accuracy studies" (STARD). 14 The research protocol was approved by the institutional ethical review board and written informed consent was obtained from all patients.
| Participants
An established imaging cohort of male adult haemophilia patients, born between 1980-1995, was invited for this cross-sectional diagnostic accuracy study. 5 Inclusion criteria were moderate or severe haemophilia (≤5% factor VIII or IX activity) and at most 1 joint with moderate-severe arthropathy on X-rays (Pettersson score ≥4 15 ).
Exclusion criteria were a history of inhibitors for clotting factor concentrates or a contraindication for MRI. Additional haemophilia patients fulfilling the same in-and exclusion criteria were invited to achieve an adequate sample size (see "Sample size").
| Imaging
Bilateral knees and ankles of patients were examined by both POC-US and MRI on the same day. The index test was POC-US according to the Haemophilia Early Arthropathy Detection with UltraSound (HEAD-US) scanning protocol and score. 13 A single ultrasound scanner (Esaote, type MyLab25 Gold, Italy) with a linear probe (adjustable central frequency at 7.5, 10, and 12 MHz) was used. POC-US was performed by 1 medical doctor who followed a course on imaging physics, received repeated HEAD-US training and scanned over 200 joints before the start of this study. POC-US was performed without knowledge of MRI results. According to the HEAD-US protocol, synovial tissue was assessed in the major joint recesses and scored as "absent/minimal"; "mild/moderate"; or "severe".
Cartilage and bone surface were assessed at 1 surface per joint: the femoral condyles in the knees (in hyperflexion) and the talar dome in the ankles (in plantar flexion). 
| Sample size
The sample size was based on our aim to establish the diagnostic accuracy of POC-US for synovial hypertrophy. For clinical interpretation, the positive and negative predictive values are the most valuable diagnostic accuracy parameters. Based on preliminary data, the prevalence of synovial hypertrophy in the imaging cohort was estimated at 23%. 5 Based on recent data on a different ultrasound protocol, 9 a sensitivity of 90% and a specificity of 95% were expected with POC-US. The minimal acceptable positive and negative predictive values were considered to be ≥70%. Including at least 24 patients would therefore suffice to detect a positive predictive value of 91% (95% confidence interval (CI): 71-99) and a negative predictive value of 97% (CI: 91-100).
| Analysis
Medians with interquartile ranges (IQR) or percentages were cal- 
| RE SULTS
In Baseline patient and joint characteristics are presented in Table 1 .
The median age of patients studied was 26.5 years (IQR: 23.0-29.5).
In total, 17/24 patients (71%) had severe haemophilia A and the majority of patients (75%) received prophylaxis. Most joints (81%) had a history of bleeding although minimal X-ray changes were observed in 18% of joints only (median Pettersson score: 0, range: 0-6).
| Test results
POC-US and MRI were performed on the same day in all patients.
No adverse events occurred during this study. Although MRI abnormalities were present in 68% of joints, minimal abnormali- Table 2 .
| Diagnostic accuracy estimates
The presence/absence of synovial hypertrophy was correctly identified using POC-US in 94% (CI: 86-100). As shown in Figure 2 , synovial hypertrophy can be clearly visualized by POC-US. For synovial hypertrophy POC-US had a sensitivity of 89% (CI: 67-99),
specificity of 99% (CI: 93-100), positive predictive value of 94% (CI: 73-100) and a negative predictive value of 97% (CI: 91-100).
The accuracy of POC-US for synovial hypertrophy was comparable in knees and ankles, except for a higher sensitivity (100% in knees vs 88% in ankles) and lower positive predictive value in knees (75% in knees vs 100% in ankles) ( Table 3) . A strong correlation between the ordinal HEAD-US score and IPSG MRI score for the severity of synovial hypertrophy was observed (r = .90, P < .01).
Peripheral cartilage abnormalities and bone surface irregularities can be visualized by POC-US as well, as shown in Figure 3 . The over- and 87% respectively, the wide confidence intervals included the minimal acceptable threshold of 70% (Table 3 ). The HEAD-US score showed a strong correlation with the IPSG MRI score for severity of cartilage abnormalities (r = .73, P < .01) and bone surface irregularities (r = .88, P < .01). 
| D ISCUSS I ON

| Comparison with other studies
Although studies comparing ultrasound with MRI in haemophilia were performed previously, 9,10 none of them used point-of-care ultrasound. Recently, Doria et al reported the diagnostic accuracy of ultrasound in patient with haemophillia or von Willebrand disease. 10 Ultrasound was performed and interpreted by sonographers and radiologists according to a comprehensive ultrasound protocol described by Zukotynski. 22 Observes were not blinded for MRI findings in order to study maximum achievable diagnostic accuracy. The overall prevalence of synovial hypertrophy was 93% (compared to 20% in our study). Ultrasound was highly sensitive (100%, CI: 95-100) in detecting synovial hypertrophy although the specificity of detection of synovial hypertrophy in ankle joints was 50% only (CI:
7-93) ( Table 4) . Sierra Aisa et al studied haemophilia patients, aged 4-82 years, using ultrasound and MRI. 9 The ultrasound protocol described by Zukotynski et al 22, 23 was used in their study too. The overall prevalence of synovial hypertrophy was 27%. 9 Diagnostic accuracy parameters were calculated from the results presented and are shown in Table 4 .
Even though the populations and study designs of previous studies differed from our study, ultrasound showed high positive and . 24 More detailed ultrasound examination by an experienced musculoskeletal radiologist and/or using advanced ultrasound equipment is expected to reveal more subtle changes and may result in an even better diagnostic accuracy of ultrasound.
However, the clinical relevance of these subtle changes remains to be established. 
| Clinical application
Point-of-care ultrasound is increasingly used in haemophilia patients to obtain direct information of joint status. [25] [26] [27] [28] Operators should have received proper training before implementation of POC-US in haemophilia care in order to avoid incorrect diagnosis and misuse. Recommendations and guidelines on training standards, appropriate use and quality assurance have therefore been described. 29 Although soft tissue abnormalities in joints may be accurately evaluated by ultrasound, ultrasound differentiation between synovial hypertrophy with or without haemosiderin deposits is unreliable. 24, 30, 31 Results on synovial hypertrophy in this study therefore represent both synovial hypertrophy with and synovial hypertrophy without haemosiderin deposits. In the evaluated population with limited arthropathy, synovial hypertrophy and haemosiderin were both present or both absent in the majority of joints. However, 5% of joints without synovial hypertrophy on ultrasound showed haemosiderin deposits on MRI. If detection of haemosiderin or differentiation between synovial hypertrophy with or without haemosiderin is clinically indicated, a more detailed evaluation using joint MRI may be warranted.
Ultrasound may be used to evaluate cartilage and bone surfaces too. In our study, the overall accuracy of POC-US in the detection of cartilage abnormalities and bone surface irregularities was based on the presence/absence of cartilage abnormalities and bone irregularities on ultrasound and MRI. The location and severity of abnormalities were not compared one-to-one with MRI.
Furthermore, because ultrasound waves are reflected at bony surfaces, primarily the peripheral joint surfaces could be evaluated.
As blood-induced joint damage is expected to affect the entire joint, the cartilage and bone status of select target surfaces provide a general rather that a detailed indication of the joint status.
Taken together, our results on the POC-US accuracy therefore represent the presence/absence of any cartilage abnormality and any bone irregularity only, and MRI continues to be the best imaging modality for complete and accurate assessment of cartilage and bone alterations as these cannot be ruled out by ultrasound alone.
A recent report showed that synovial hypertrophy detected by MRI is predictive for joint bleeding in patients with limited arthropathy. 7 As POC-US can accurately evaluate the presence of synovial hypertrophy, it may be used to monitor treatment and/or to identify joints at risk of bleeding in these patients. Further studies using 
| CON CLUS ION
